Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

NCT03802058 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped The study was halted because enrollment was too slow

Conditions

Carcinoma, Non-Small-Cell Lung
Squamous Cell Carcinoma

Interventions

DRUG: Nab-paclitaxel
DRUG: Carboplatin
RADIATION: Thoracic radiation therapy

Sponsor

Wuhan University

Collaborators

[object Object]